{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:13:21Z","timestamp":1790176401849,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T00:00:00Z","timestamp":1496016000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12185-017-2257-6","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T06:49:17Z","timestamp":1496040557000},"page":"34-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Epigenetic dysregulation of hematopoietic stem cells and preleukemic state"],"prefix":"10.1007","volume":"106","author":[{"given":"Hiroyoshi","family":"Kunimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,29]]},"reference":[{"issue":"1","key":"2257_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma DP, Bejar R, Jaiswal S, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126(1):9\u201316.","journal-title":"Blood"},{"issue":"1","key":"2257_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2016.112","volume":"17","author":"AS Sperling","year":"2017","unstructured":"Sperling AS, Gibson CJ, Ebert BL. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer. 2017;17(1):5\u201319.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2257_CR3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc3343","volume":"12","author":"AH Shih","year":"2012","unstructured":"Shih AH, Abdel-Wahab O, Patel JP, et al. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer. 2012;12(9):599\u2013612.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2257_CR4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.molmed.2016.06.003","volume":"22","author":"S Akunuru","year":"2016","unstructured":"Akunuru S, Geiger H. Aging, clonality, and rejuvenation of hematopoietic stem cells. Trends Mol Med. 2016;22(8):701\u201312.","journal-title":"Trends Mol Med"},{"issue":"6","key":"2257_CR5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM197308092890608","volume":"289","author":"RD Barr","year":"1973","unstructured":"Barr RD, Fialkow PJ. Clonal origin of chronic myelocytic leukemia. N Engl J Med. 1973;289(6):307\u20139.","journal-title":"N Engl J Med"},{"issue":"17","key":"2257_CR6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","volume":"295","author":"JW Adamson","year":"1976","unstructured":"Adamson JW, Fialkow PJ, Murphy S, et al. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med. 1976;295(17):913\u20136.","journal-title":"N Engl J Med"},{"issue":"4","key":"2257_CR7","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.1365-2141.1997.1933010.x","volume":"97","author":"KM Champion","year":"1997","unstructured":"Champion KM, Gilbert JG, Asimakopoulos FA, et al. Clonal haematopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol. 1997;97(4):920\u20136.","journal-title":"Br J Haematol"},{"issue":"4","key":"2257_CR8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1399-0004.2004.00310.x","volume":"66","author":"C Hatakeyama","year":"2004","unstructured":"Hatakeyama C, Anderson CL, Beever CL, et al. The dynamics of X-inactivation skewing as women age. Clin Genet. 2004;66(4):327\u201332.","journal-title":"Clin Genet"},{"issue":"11","key":"2257_CR9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","volume":"44","author":"L Busque","year":"2012","unstructured":"Busque L, Patel JP, Figueroa ME, et al. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet. 2012;44(11):1179\u201381.","journal-title":"Nat Genet"},{"issue":"7488","key":"2257_CR10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","volume":"506","author":"LI Shlush","year":"2014","unstructured":"Shlush LI, Zandi S, Mitchell A, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506(7488):328\u201333.","journal-title":"Nature"},{"issue":"12","key":"2257_CR11","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","volume":"20","author":"M Xie","year":"2014","unstructured":"Xie M, Lu C, Wang J, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014;20(12):1472\u20138.","journal-title":"Nat Med"},{"issue":"26","key":"2257_CR12","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Rose SA, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477\u201387.","journal-title":"N Engl J Med"},{"issue":"26","key":"2257_CR13","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488\u201398.","journal-title":"N Engl J Med"},{"issue":"6327","key":"2257_CR14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster JJ, MacLauchlan S, Zuriaga MA, et al. Clonal hematopoiesis associated with Tet2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355(6327):842\u20137.","journal-title":"Science"},{"issue":"1","key":"2257_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","volume":"147","author":"JC Marsh","year":"2009","unstructured":"Marsh JC, Ball SE, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147(1):43\u201370.","journal-title":"Br J Haematol"},{"issue":"8","key":"2257_CR16","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","volume":"108","author":"NS Young","year":"2006","unstructured":"Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108(8):2509\u201319.","journal-title":"Blood"},{"issue":"17","key":"2257_CR17","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1182\/blood-2014-05-574889","volume":"124","author":"AG Kulasekararaj","year":"2014","unstructured":"Kulasekararaj AG, Jiang J, Smith AE, et al. Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood. 2014;124(17):2698\u2013704.","journal-title":"Blood"},{"issue":"1","key":"2257_CR18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","volume":"373","author":"T Yoshizato","year":"2015","unstructured":"Yoshizato T, Dumitriu B, Hosokawa K, et al. Somatic mutations and clonal hematopoiesis in aplastic anemia. N Engl J Med. 2015;373(1):35\u201347.","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"2257_CR19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbrc.2014.08.004","volume":"455","author":"S Aumann","year":"2014","unstructured":"Aumann S, Abdel-Wahab O. Somatic alterations and dysregulation of epigenetic modifiers in cancers. Biochem Biophys Res Commun. 2014;455(1\u20132):24\u201334.","journal-title":"Biochem Biophys Res Commun"},{"issue":"25","key":"2257_CR20","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley TJ, Ding L, Walter MJ, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med. 2010;363(25):2424\u201333.","journal-title":"N Engl J Med"},{"issue":"4","key":"2257_CR21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/ng.788","volume":"43","author":"XJ Yan","year":"2011","unstructured":"Yan XJ, Xu J, Gu ZH, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;43(4):309\u201315.","journal-title":"Nat Genet"},{"issue":"7","key":"2257_CR22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1200\/JCO.2011.39.2092","volume":"30","author":"G Marcucci","year":"2012","unstructured":"Marcucci G, Metzeler KH, Schwind S, et al. Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. J Clin Oncol. 2012;30(7):742\u201350.","journal-title":"J Clin Oncol"},{"issue":"7159","key":"2257_CR23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature06146","volume":"449","author":"D Jia","year":"2007","unstructured":"Jia D, Jurkowska RZ, Zhang X, et al. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature. 2007;449(7159):248\u201351.","journal-title":"Nature"},{"issue":"38","key":"2257_CR24","doi-asserted-by":"crossref","first-page":"29091","DOI":"10.1074\/jbc.M110.142513","volume":"285","author":"C Holz-Schietinger","year":"2010","unstructured":"Holz-Schietinger C, Reich NO. The inherent processivity of the human de novo methyltransferase 3A (DNMT3A) is enhanced by DNMT3L. J Biol Chem. 2010;285(38):29091\u2013100.","journal-title":"J Biol Chem"},{"issue":"25","key":"2257_CR25","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2013-02-483487","volume":"122","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Zhao H, Hardikar S, et al. A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood. 2013;122(25):4086\u20139.","journal-title":"Blood"},{"issue":"4","key":"2257_CR26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","volume":"25","author":"DA Russler-Germain","year":"2014","unstructured":"Russler-Germain DA, Spencer DH, Young MA, et al. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell. 2014;25(4):442\u201354.","journal-title":"Cancer Cell"},{"issue":"4","key":"2257_CR27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1084\/jem.20060750","volume":"204","author":"Y Tadokoro","year":"2007","unstructured":"Tadokoro Y, Ema H, Okano M, et al. De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells. J Exp Med. 2007;204(4):715\u201322.","journal-title":"J Exp Med"},{"issue":"1","key":"2257_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng.1009","volume":"44","author":"GA Challen","year":"2011","unstructured":"Challen GA, Sun D, Jeong M, et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet. 2011;44(1):23\u201331.","journal-title":"Nat Genet"},{"issue":"3","key":"2257_CR29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.stem.2014.06.018","volume":"15","author":"GA Challen","year":"2014","unstructured":"Challen GA, Sun D, Mayle A, et al. Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell. 2014;15(3):350\u201364.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"2257_CR30","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1073\/pnas.1400150111","volume":"111","author":"J Xu","year":"2014","unstructured":"Xu J, Wang YY, Dai YJ, et al. DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression\/DNA methylation in hematopoietic cells. Proc Natl Acad Sci USA. 2014;111(7):2620\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2257_CR31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood-2014-08-594564","volume":"125","author":"H Celik","year":"2015","unstructured":"Celik H, Mallaney C, Kothari A, et al. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation. Blood. 2015;125(4):619\u201328.","journal-title":"Blood"},{"issue":"4","key":"2257_CR32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood-2014-08-594648","volume":"125","author":"A Mayle","year":"2015","unstructured":"Mayle A, Yang L, Rodriguez B, et al. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. Blood. 2015;125(4):629\u201338.","journal-title":"Blood"},{"issue":"5","key":"2257_CR33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/leu.2015.358","volume":"30","author":"OA Guryanova","year":"2016","unstructured":"Guryanova OA, Lieu YK, Garrett-Bakelman FE, et al. Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells. Leukemia. 2016;30(5):1133\u201342.","journal-title":"Leukemia"},{"issue":"12","key":"2257_CR34","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/nm.4210","volume":"22","author":"OA Guryanova","year":"2016","unstructured":"Guryanova OA, Shank K, Spitzer B, et al. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling. Nat Med. 2016;22(12):1488\u201395.","journal-title":"Nat Med"},{"issue":"12","key":"2257_CR35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","volume":"366","author":"JP Patel","year":"2012","unstructured":"Patel JP, G\u00f6nen M, Figueroa M, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366(12):1079\u201389.","journal-title":"N Engl J Med"},{"issue":"7","key":"2257_CR36","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1158\/1078-0432.CCR-14-0327","volume":"21","author":"AR Sehgal","year":"2015","unstructured":"Sehgal AR, Gimotty PA, Zhao J, et al. DNMT3A mutational status affects the results of dose-escalated induction therapy in acute myelogenous leukemia. Clin Cancer Res. 2015;21(7):1614\u201320.","journal-title":"Clin Cancer Res"},{"issue":"14","key":"2257_CR37","first-page":"4075","volume":"62","author":"R Ono","year":"2002","unstructured":"Ono R, Taki T, Taketani T, et al. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res. 2002;62(14):4075\u201380.","journal-title":"Cancer Res"},{"issue":"5929","key":"2257_CR38","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930\u20135.","journal-title":"Science"},{"issue":"6047","key":"2257_CR39","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","volume":"333","author":"S Ito","year":"2011","unstructured":"Ito S, Shen L, Dai Q, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011;333(6047):1300\u20133.","journal-title":"Science"},{"issue":"6047","key":"2257_CR40","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.1210944","volume":"333","author":"YF He","year":"2011","unstructured":"He YF, Li BZ, Li Z, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011;333(6047):1303\u20137.","journal-title":"Science"},{"issue":"3","key":"2257_CR41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cell.2011.03.022","volume":"145","author":"JU Guo","year":"2011","unstructured":"Guo JU, Su Y, Zhong C, et al. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell. 2011;145(3):423\u201334.","journal-title":"Cell"},{"issue":"45","key":"2257_CR42","doi-asserted-by":"crossref","first-page":"41991","DOI":"10.1074\/jbc.M106953200","volume":"276","author":"RJ Boorstein","year":"2001","unstructured":"Boorstein RJ, Cummings A Jr, Marenstein DR, et al. Definitive identification of mammalian 5-hydroxymethyluracil DNA N-glycosylase activity as SMUG1. J Biol Chem. 2001;276(45):41991\u20137.","journal-title":"J Biol Chem"},{"key":"2257_CR43","doi-asserted-by":"crossref","unstructured":"Kunimoto H, McKenney AS, Meydan C, et al. Aid is a key regulator of myeloid\/erythroid differentiation and DNA methylation in hematopoietic stem\/progenitor cells. Blood. 2017 (in press).","DOI":"10.1182\/blood-2016-06-721977"},{"issue":"3","key":"2257_CR44","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/0008-5472.CAN-06-3123","volume":"67","author":"V Valinluck","year":"2007","unstructured":"Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 2007;67(3):946\u201350.","journal-title":"Cancer Res"},{"issue":"7433","key":"2257_CR45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature11742","volume":"493","author":"Q Chen","year":"2013","unstructured":"Chen Q, Chen Y, Bian C, et al. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature. 2013;493(7433):561\u20134.","journal-title":"Nature"},{"issue":"4","key":"2257_CR46","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molcel.2012.12.019","volume":"49","author":"P Vella","year":"2013","unstructured":"Vella P, Scelfo A, Jammula S, et al. Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol Cell. 2013;49(4):645\u201356.","journal-title":"Mol Cell"},{"issue":"5","key":"2257_CR47","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/emboj.2012.357","volume":"32","author":"R Deplus","year":"2013","unstructured":"Deplus R, Delatte B, Schwinn MK, et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1\/COMPASS. EMBO J. 2013;32(5):645\u201355.","journal-title":"EMBO J"},{"issue":"22","key":"2257_CR48","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau F, Dupont S, Della Valle V, et al. Mutation in TET2 in myeloid cancers. N Engl J Med. 2009;360(22):2289\u2013301.","journal-title":"N Engl J Med"},{"issue":"7","key":"2257_CR49","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.391","volume":"41","author":"SM Langemeijer","year":"2009","unstructured":"Langemeijer SM, Kuiper RP, Berends M, et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet. 2009;41(7):838\u201342.","journal-title":"Nat Genet"},{"issue":"1","key":"2257_CR50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","volume":"114","author":"O Abdel-Wahab","year":"2009","unstructured":"Abdel-Wahab O, Mullally A, Hedvat C, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 2009;114(1):144\u20137.","journal-title":"Blood"},{"issue":"25","key":"2257_CR51","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1182\/blood-2009-02-205690","volume":"113","author":"AM Jankowska","year":"2009","unstructured":"Jankowska AM, Szpurka H, Tiu RV, et al. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic\/myeloproliferative neoplasms. Blood. 2009;113(25):6403\u201310.","journal-title":"Blood"},{"issue":"1","key":"2257_CR52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","volume":"20","author":"C Quivoron","year":"2011","unstructured":"Quivoron C, Couronn\u00e9 L, Della Valle V, et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell. 2011;20(1):25\u201338.","journal-title":"Cancer Cell"},{"issue":"2","key":"2257_CR53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","volume":"46","author":"M Sakata-Yanagimoto","year":"2014","unstructured":"Sakata-Yanagimoto M, Enami T, Yoshida K, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(2):171\u20135.","journal-title":"Nat Genet"},{"issue":"7","key":"2257_CR54","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","volume":"120","author":"F Lemonnier","year":"2012","unstructured":"Lemonnier F, Couronn\u00e9 L, Parrens M, et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood. 2012;120(7):1466\u20139.","journal-title":"Blood"},{"issue":"12","key":"2257_CR55","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3324\/haematol.2013.088740","volume":"98","author":"F Asmar","year":"2013","unstructured":"Asmar F, Punj V, Christensen J, et al. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica. 2013;98(12):1912\u201320.","journal-title":"Haematologica"},{"issue":"7325","key":"2257_CR56","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature09586","volume":"468","author":"M Ko","year":"2010","unstructured":"Ko M, Huang Y, Jankowska AM, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature. 2010;468(7325):839\u201343.","journal-title":"Nature"},{"issue":"6","key":"2257_CR57","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","volume":"18","author":"ME Figueroa","year":"2010","unstructured":"Figueroa ME, Abdel-Wahab O, Lu C, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 2010;18(6):553\u201367.","journal-title":"Cancer Cell"},{"issue":"2","key":"2257_CR58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4161\/epi.7.2.19015","volume":"7","author":"J Yamazaki","year":"2012","unstructured":"Yamazaki J, Taby R, Vasanthakumar A, et al. Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia. Epigenetics. 2012;7(2):201\u20137.","journal-title":"Epigenetics"},{"issue":"9","key":"2257_CR59","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1101\/gad.260174.115","volume":"29","author":"KD Rasmussen","year":"2015","unstructured":"Rasmussen KD, Jia G, Johansen JV, et al. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis. Genes Dev. 2015;29(9):910\u201322.","journal-title":"Genes Dev"},{"issue":"9","key":"2257_CR60","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1182\/blood-2010-12-324707","volume":"118","author":"E Pronier","year":"2011","unstructured":"Pronier E, Almire C, Mokrani H, et al. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors. Blood. 2011;118(9):2551\u20135.","journal-title":"Blood"},{"issue":"1","key":"2257_CR61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu W, Yang H, Liu Y, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011;19(1):17\u201330.","journal-title":"Cancer Cell"},{"issue":"4","key":"2257_CR62","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.molcel.2014.12.023","volume":"57","author":"Y Wang","year":"2015","unstructured":"Wang Y, Xiao M, Chen X, et al. WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation. Mol Cell. 2015;57(4):662\u201373.","journal-title":"Mol Cell"},{"issue":"5","key":"2257_CR63","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.celrep.2014.11.004","volume":"9","author":"R Rampal","year":"2014","unstructured":"Rampal R, Alkalin A, Madzo J, et al. DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. Cell Rep. 2014;9(5):1841\u201355.","journal-title":"Cell Rep"},{"issue":"1","key":"2257_CR64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","volume":"20","author":"K Moran-Crusio","year":"2011","unstructured":"Moran-Crusio K, Reavie L, Shih A, et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell. 2011;20(1):11\u201324.","journal-title":"Cancer Cell"},{"issue":"17","key":"2257_CR65","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","volume":"118","author":"Z Li","year":"2011","unstructured":"Li Z, Cai X, Cai CL, et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood. 2011;118(17):4509\u201318.","journal-title":"Blood"},{"issue":"35","key":"2257_CR66","doi-asserted-by":"crossref","first-page":"14566","DOI":"10.1073\/pnas.1112317108","volume":"108","author":"M Ko","year":"2011","unstructured":"Ko M, Bandukwala HS, An J, et al. Ten\u2013Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc Natl Acad Sci USA. 2011;108(35):14566\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2257_CR67","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1038\/leu.2012.94","volume":"26","author":"K Shide","year":"2012","unstructured":"Shide K, Kameda T, Shimoda H, et al. TET2 is essential for survival and hematopoietic stem cell homeostasis. Leukemia. 2012;26(10):2216\u201323.","journal-title":"Leukemia"},{"key":"2257_CR68","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/srep00273","volume":"2","author":"H Kunimoto","year":"2012","unstructured":"Kunimoto H, Fukuchi Y, Sakurai M, et al. Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells. Sci Rep. 2012;2:273.","journal-title":"Sci Rep"},{"issue":"18","key":"2257_CR69","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1182\/blood-2014-01-552471","volume":"123","author":"H Kunimoto","year":"2014","unstructured":"Kunimoto H, Fukuchi Y, Sakurai M, et al. Tet2-mutated myeloid progenitors possess aberrant in vitro self-renewal capacity. Blood. 2014;123(18):2897\u20139.","journal-title":"Blood"},{"issue":"1","key":"2257_CR70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.stem.2013.06.003","volume":"13","author":"SJ Song","year":"2013","unstructured":"Song SJ, Ito K, Ala U, et al. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell. 2013;13(1):87\u2013101.","journal-title":"Cell Stem Cell"},{"issue":"22","key":"2257_CR71","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","unstructured":"Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059\u201374.","journal-title":"N Engl J Med"},{"issue":"14","key":"2257_CR72","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","volume":"123","author":"P Lundberg","year":"2014","unstructured":"Lundberg P, Karow A, Nienhold R, et al. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood. 2014;123(14):2220\u20138.","journal-title":"Blood"},{"issue":"4","key":"2257_CR73","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ccell.2015.03.009","volume":"27","author":"AH Shih","year":"2015","unstructured":"Shih AH, Jiang Y, Meydan C, et al. Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia. Cancer Cell. 2015;27(4):502\u201315.","journal-title":"Cancer Cell"},{"issue":"12","key":"2257_CR74","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1084\/jem.20131144","volume":"210","author":"T Muto","year":"2013","unstructured":"Muto T, Sashida G, Oshima M, et al. Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders. J Exp Med. 2013;210(12):2627\u201339.","journal-title":"J Exp Med"},{"issue":"1","key":"2257_CR75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20150524","volume":"213","author":"MA Hatlen","year":"2016","unstructured":"Hatlen MA, Arora K, Vacic V, et al. Integrative genetic analysis of mouse and human AML identifies cooperating disease alleles. J Exp Med. 2016;213(1):25\u201334.","journal-title":"J Exp Med"},{"issue":"2","key":"2257_CR76","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1182\/blood-2014-04-555508","volume":"125","author":"T Kameda","year":"2015","unstructured":"Kameda T, Shide K, Yamaji T, et al. Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator. Blood. 2015;125(2):304\u201315.","journal-title":"Blood"},{"issue":"2","key":"2257_CR77","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/blood-2014-04-567024","volume":"125","author":"E Chen","year":"2015","unstructured":"Chen E, Schneider RK, Breyfogle LJ, et al. Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms. Blood. 2015;125(2):327\u201335.","journal-title":"Blood"},{"issue":"8","key":"2257_CR78","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.celrep.2015.10.037","volume":"13","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Chen L, Dawlaty MM, et al. Combined loss of Tet1 and Tet2 promotes B cell, but not myeloid malignancies, in mice. Cell Rep. 2015;13(8):1692\u2013704.","journal-title":"Cell Rep"},{"issue":"1","key":"2257_CR79","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","volume":"366","author":"L Couronn\u00e9","year":"2012","unstructured":"Couronn\u00e9 L, Bastard C, Bernard OA. TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med. 2012;366(1):95\u20136.","journal-title":"N Engl J Med"},{"issue":"6","key":"2257_CR80","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/leu.2016.29","volume":"30","author":"L Scourzic","year":"2016","unstructured":"Scourzic L, Couronn\u00e9 L, Pedersen MT, et al. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice. Leukemia. 2016;30(6):1388\u201398.","journal-title":"Leukemia"},{"issue":"9","key":"2257_CR81","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ng.3610","volume":"48","author":"X Zhang","year":"2016","unstructured":"Zhang X, Su J, Jeong M, et al. DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells. Nat Genet. 2016;48(9):1014\u201323.","journal-title":"Nat Genet"},{"issue":"7295","key":"2257_CR82","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature08966","volume":"465","author":"JC Scheuermann","year":"2010","unstructured":"Scheuermann JC, de Ayala Alonso AG, Oktaba K, et al. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature. 2010;465(7295):243\u20137.","journal-title":"Nature"},{"issue":"6","key":"2257_CR83","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","volume":"145","author":"V Gelsi-Boyer","year":"2009","unstructured":"Gelsi-Boyer V, Trouplin V, Ad\u00e9la\u00efde J, et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol. 2009;145(6):788\u2013800.","journal-title":"Br J Haematol"},{"issue":"5","key":"2257_CR84","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2010.20","volume":"24","author":"J Boultwood","year":"2010","unstructured":"Boultwood J, Perry J, Pellagatti A, et al. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia. 2010;24(5):1062\u20135.","journal-title":"Leukemia"},{"issue":"14","key":"2257_CR85","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2010-10-311019","volume":"118","author":"AM Jankowska","year":"2011","unstructured":"Jankowska AM, Makishima H, Tiu RV, et al. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood. 2011;118(14):3932\u201341.","journal-title":"Blood"},{"issue":"2","key":"2257_CR86","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/0008-5472.CAN-09-3783","volume":"70","author":"O Abdel-Wahab","year":"2010","unstructured":"Abdel-Wahab O, Manshouri T, Patel J, et al. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias. Cancer Res. 2010;70(2):447\u201352.","journal-title":"Cancer Res"},{"issue":"26","key":"2257_CR87","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1182\/blood-2011-08-368225","volume":"118","author":"KH Metzeler","year":"2011","unstructured":"Metzeler KH, Becker H, Maharry K, et al. ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN favorable genetic category. Blood. 2011;118(26):6920\u20139.","journal-title":"Blood"},{"issue":"18","key":"2257_CR88","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1200\/JCO.2010.33.4938","volume":"29","author":"F Thol","year":"2011","unstructured":"Thol F, Friesen I, Damm F, et al. Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. J Clin Oncol. 2011;29(18):2499\u2013506.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2257_CR89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","volume":"22","author":"O Abdel-Wahab","year":"2012","unstructured":"Abdel-Wahab O, Adli M, LaFave LM, et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell. 2012;22(2):180\u201393.","journal-title":"Cancer Cell"},{"issue":"11","key":"2257_CR90","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1172\/JCI70739","volume":"123","author":"D Inoue","year":"2013","unstructured":"Inoue D, Kitaura J, Togami K, et al. Myelodysplastic syndromes are induced by histone methylation-altering ASXL1 mutations. J Clin Invest. 2013;123(11):4627\u201340.","journal-title":"J Clin Invest"},{"issue":"4","key":"2257_CR91","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1182\/blood-2013-05-500272","volume":"123","author":"J Wang","year":"2014","unstructured":"Wang J, Li Z, He Y, et al. Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice. Blood. 2014;123(4):541\u201353.","journal-title":"Blood"},{"issue":"12","key":"2257_CR92","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20131141","volume":"210","author":"O Abdel-Wahab","year":"2013","unstructured":"Abdel-Wahab O, Gao J, Adli M, et al. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. J Exp Med. 2013;210(12):2641\u201359.","journal-title":"J Exp Med"},{"key":"2257_CR93","doi-asserted-by":"crossref","first-page":"28789","DOI":"10.1038\/srep28789","volume":"6","author":"H Shi","year":"2016","unstructured":"Shi H, Yamamoto S, Sheng M, et al. ASXL1 plays an important role in erythropoiesis. Sci Rep. 2016;6:28789.","journal-title":"Sci Rep"},{"issue":"4","key":"2257_CR94","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/leu.2014.301","volume":"29","author":"D Inoue","year":"2015","unstructured":"Inoue D, Kitaura J, Matsui H, et al. SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS. Leukemia. 2015;29(4):847\u201357.","journal-title":"Leukemia"},{"issue":"6009","key":"2257_CR95","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330(6009):1410\u20133.","journal-title":"Science"},{"issue":"7","key":"2257_CR96","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"Bott M, Brevet M, Taylor BS, et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet. 2011;43(7):668\u201372.","journal-title":"Nat Genet"},{"issue":"7","key":"2257_CR97","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pe\u00f1a-Llopis","year":"2012","unstructured":"Pe\u00f1a-Llopis S, Vega-Rub\u00edn-de-Celis S, Liao A, et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet. 2012;44(7):751\u20139.","journal-title":"Nat Genet"},{"issue":"6101","key":"2257_CR98","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","volume":"337","author":"A Dey","year":"2012","unstructured":"Dey A, Seshasayee D, Noubade R, et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science. 2012;337(6101):1541\u20136.","journal-title":"Science"},{"issue":"11","key":"2257_CR99","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.3947","volume":"21","author":"LM LaFave","year":"2015","unstructured":"LaFave LM, B\u00e9guelin W, Koche R, et al. Loss of BAP1 function leads to EZH2-dependent transformation. Nat Med. 2015;21(11):1344\u20139.","journal-title":"Nat Med"},{"issue":"3","key":"2257_CR100","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/leu.2016.364","volume":"31","author":"HP Koeffler","year":"2017","unstructured":"Koeffler HP, Leong G. Preleukemia: one name, many meanings. Leukemia. 2017;31(3):534\u201342.","journal-title":"Leukemia"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-017-2257-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2257-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2257-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T18:21:16Z","timestamp":1497982876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-017-2257-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,29]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2257"],"URL":"https:\/\/doi.org\/10.1007\/s12185-017-2257-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,29]]}}}